DE60043459D1 - Pharmazeutische flüssige Suspensionen - Google Patents
Pharmazeutische flüssige SuspensionenInfo
- Publication number
- DE60043459D1 DE60043459D1 DE60043459T DE60043459T DE60043459D1 DE 60043459 D1 DE60043459 D1 DE 60043459D1 DE 60043459 T DE60043459 T DE 60043459T DE 60043459 T DE60043459 T DE 60043459T DE 60043459 D1 DE60043459 D1 DE 60043459D1
- Authority
- DE
- Germany
- Prior art keywords
- liquid suspensions
- pharmaceutical liquid
- particles
- liquid
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04013422A EP1452171B1 (de) | 2000-10-13 | 2000-10-13 | Pharmazeutische flüssige Suspensionen |
| EP00973483A EP1328255A1 (de) | 2000-10-13 | 2000-10-13 | Zusammenstzung und verfahren für injizierbare flüssigkeiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60043459D1 true DE60043459D1 (de) | 2010-01-14 |
Family
ID=41401562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60043459T Expired - Lifetime DE60043459D1 (de) | 2000-10-13 | 2000-10-13 | Pharmazeutische flüssige Suspensionen |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP1449523A1 (de) |
| AT (1) | ATE450253T1 (de) |
| DE (1) | DE60043459D1 (de) |
| DK (1) | DK1452171T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2498774A (en) * | 2012-01-27 | 2013-07-31 | Bruce Roser | Glass-stabilised biological materials and syringe |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR78151B (de) * | 1982-04-05 | 1984-09-26 | Alcon Lab Inc | |
| DE229810T1 (de) * | 1985-07-09 | 1987-11-05 | Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire | Beschuetzung von proteinen und aehnlichem. |
| GB9010742D0 (en) * | 1990-05-14 | 1990-07-04 | Quadrant Bioresources Ltd | Stabilization of biological macromolecular substances |
| US5496535A (en) * | 1991-04-12 | 1996-03-05 | Alliance Pharmaceutical Corp. | Fluorocarbon contrast media for use with MRI and radiographic imaging |
| AU3924193A (en) * | 1992-03-19 | 1993-10-21 | Allergan, Inc. | Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid |
| DE69426292T2 (de) * | 1993-02-23 | 2001-05-17 | Genentech, Inc. | Stabilisierung von mit organischen lösungsmittel behandelten polypeptiden mit einem hilfsstoff |
| MX9701394A (es) * | 1994-08-04 | 1998-03-31 | Quadrant Holdings Cambridge | Sistemas de administracion de solidos para la liberacion controlada de moleculas incorporadas en losmismos y metodos para hacer los mismos. |
| GB9705588D0 (en) * | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
| WO1999047174A1 (en) * | 1998-03-18 | 1999-09-23 | Cambridge Biostability Limited | Amorphous glasses for stabilising sensitive products |
| US6190701B1 (en) * | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
-
2000
- 2000-10-13 EP EP04010391A patent/EP1449523A1/de not_active Withdrawn
- 2000-10-13 EP EP04013422A patent/EP1452171B1/de not_active Expired - Lifetime
- 2000-10-13 DE DE60043459T patent/DE60043459D1/de not_active Expired - Lifetime
- 2000-10-13 DK DK04013422.3T patent/DK1452171T3/da active
- 2000-10-13 AT AT04013422T patent/ATE450253T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE450253T1 (de) | 2009-12-15 |
| EP1452171B1 (de) | 2009-12-02 |
| EP1452171A2 (de) | 2004-09-01 |
| EP1452171A3 (de) | 2004-11-10 |
| DK1452171T3 (da) | 2010-04-06 |
| EP1449523A1 (de) | 2004-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60219006D1 (de) | Modifizierte und stabilizierte gdf propeptide und ihre verwendungen | |
| ATE395042T1 (de) | Darreichungsformen welche mikropartikel und treibgas enthalten | |
| ID26033A (id) | Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan | |
| BR0206551B1 (pt) | bolsa plástica de múltiplas pregas descartável e sistema para melhorar a descarga de um material bombeável de uma bolsa plástica. | |
| BRPI0408065A (pt) | pó impregnado, processo de fabricação do mesmo e sua utilização | |
| ATE551363T1 (de) | Verwendung von antikörper gegen interleukin-4 rezeptor und deren zusammensetzungen | |
| ATE345277T1 (de) | Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern | |
| ATE507822T1 (de) | Stabilisierte zusammensetzungen von faktor-vii- polypeptiden | |
| ATE433961T1 (de) | Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften | |
| FI20010085A (fi) | Menetelmä ja laitteisto projektiopinnan muodostamiseksi | |
| DK1117440T3 (da) | Farmaceutiske sammensætninger indeholdende paclitaxel | |
| DE60234945D1 (de) | Pulver zur nasalen verabreichung von wirkstoffen | |
| LU92749I2 (fr) | Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) | |
| EA200301275A1 (ru) | Капсулы для ингаляции | |
| DE602005025082D1 (de) | Nicht-lamellare zubereitungen von dioleoyl-phosphatidyl ethanolamin und polysorbat80 | |
| ATE407674T1 (de) | Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin | |
| EA200201061A1 (ru) | Система для транспорта активных веществ в биологической системе | |
| AR054544A1 (es) | Concentrados estables de te | |
| DE60043459D1 (de) | Pharmazeutische flüssige Suspensionen | |
| TWI255737B (en) | A straw for the conservation of small quantities of substances, in particular biological liquids | |
| DE69928279D1 (de) | Lungensurfactant zubereitungen enthaltendes behandlungset | |
| ATE295152T1 (de) | Carotinoidtrockenpulver mit einer multi-kern struktur | |
| DE60045894D1 (de) | Extraktion von polysaccharide aus algenprotein und verwendung davon | |
| BR0110605A (pt) | Recipiente suspenso para essências com meios para sua absorção e difusão do seu perfume para o meio ambiente | |
| DE60218744D1 (de) | Partikuläre zusammensetzung enthaltend eine lipophile flüssigkeit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: NOVA BIO-PHARMA TECHNOLOGIES LTD., PETERBOROUG, GB |
|
| 8364 | No opposition during term of opposition |